Clinical trial
Computerized Assessment for Patients With Cancer
NCT00194493 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00194493 |
|---|---|
| Title | Computerized Assessment for Patients With Cancer |
| Official title | Computerized Assessment for Patients With Cancer |
| Acronym | ESRA-C |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | University of Washington |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Behavioral |
| Interventions | ESRA-C |
| Enrollment | 1,058 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | May 4, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: